Oncology, Cardiology and Immunology to Drive the Epigenetics Market
According to a new market research report „Epigenetics Market by Product (Kit, Enzymes, Reagent, NGS, Mass Spectrometer, PCR, Bioinformatics), Application (Oncology, Cardiology, Immunology), Technology (DNA Methylation, Histone Modification), End User (Academic, CRO) – Global Forecast to 2022“, published by MarketsandMarkets™, the dna methylation market is projected to reach USD 1,605.7 million by 2022 from an estimated USD 854.0 million in 2017, at a CAGR of 13.5% during the forecast period.
This report studies the Epigenetics Market based on type, product type, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions (and the respective countries in these regions).
It focuses on various levels of analysis industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the epigenetics technology market, and high-growth regions and their drivers, restraints, challenges, and opportunities.
This research on epigenomics market provides insights on the following:
Product Development: Product portfolios of the top players in the epigenetics technology market.
Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the epigenetics market.
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various epigenetics products and services across geographies.
Download an Illustrative Overview of the Report:
Key Market Driving Factors of Epigenomics:
The key factors that are driving the growth of epigenome market include the decreasing sequencing costs and time, increase in research activities to identify and develop inhibitors/drugs for various diseases, funding for epigenetics research, and rising prevalence of cancer.
Biopharmaceutical Companies & Personalized Medicine Driving Growth in (Epigenetics) Genome Market:
According to a press release published by the Tufts Center for the Study of Drug Development in May 2015, biopharmaceutical companies have nearly doubled their R&D investments in personalized medicine over the last five years. This will further drive the use of epigenetics tools. The expanding application of epigenetics in personalized medicine and targeted therapies, therefore, offers significant opportunities for market growth.
Epigenetics has its applications in large number of fields including oncology, drug discovery, disease diagnosis, developmental biology and plant sciences. It is one of the most widely used techniques for cancer biomarkers discovery and development. According to GLOBOCON, 2012 prevalence of cancer is growing. A high prevalence of cancer will majorly drive the epigenetics market. Furthermore, factors such as an increasing research activities and R&D funding by private and government organizations will also aid to the growth of this market.
Request Sample Pages @
Research areas of Epigenetics:
The research areas segment will be an important revenue pockets during the forecast period. By research areas, the market is divided into oncology, developmental biology, drug discovery and other epigenetics research areas. Drug discovery segment is expected to grow at a higher rate during the forecast period.
Speak to Subject Expert @ https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=896